Skip to main content

Table 5 Key characteristics of participants with and without data on legal system involvement

From: Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

Variable

A

Patients with legal involvement data

N = 609

B

Patients without legal involvement data

N = 42

P-value

Unadjusted, overall group comparison

(A vs B)

Age, mean (SD)

42.9 (12.0)

41.6 (13.2)

0.480

Male gender, n (%)

380 (62%)

31 (74%)

0.185

Ethnicity -- Caucasian, n (%)

334 (55%)

20 (48%)

0.533

   -African-American, n (%)

204 (34%)

15 (36%)

 

   -Other ethnic group, n (%)

71 (12%)

7 (17%)

 

Uninsured, n (%)

105 (18%)

13 (35%)

0.017

PANSS total, mean (SD)

86.7 (19.9)

88.2 (21.2)

0.652

SF36 MCS, mean (SD)

-1.04 (1.32)

-1.71 (1.34)

0.002

SF36 PCS, mean (SD)

-0.44 (1.04)

-0.22 (1.02)

0.189

Past year psych hospitalization: None, n (%)

417 (70%)

24 (60%)

0.216

ER past 3 months, n (%)

163 (28%)

17 (44%)

0.043

Lifetime substance use disorder diagnosis, n (%)

262 (43%)

26 (62%)

0.024

Use of alcohol to intoxication, n (%)

48 (8%)

6 (17%)

0.109

Any use of cannabis, n (%)

79 (13%)

9 (25%)

0.077

Any use of cocaine, n (%)

29 (5%)

2 (6%)

0.694

MPR ≥ 80%, n (%)

238 (44%)

11 (28%)

0.067

MPR, mean (SD)

0.53 (0.43)

0.39 (0.41)

0.043

Discontinued study, n (%)

156 (26%)

38 (90%)

< 0.001

Mean days to study discontinuation, mean (SD)

319.5 (88.9)

123.5 (125.6)

< 0.001